United States

Janssen Oncology Inc (NONE)

Track

Track

Ticker: NONE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
ROSENWALD LINDSAY A MD Large shareholder
Transaction date
Sale
Price
46.14
Quantity 80,524 -13.4%
Value US$3,895,705
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
477.19
Quantity 83,646 -27.6%
Value US$947,290
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
416.82
Quantity 439 -20.9%
Value US$4,226,600
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
30.50
Quantity 15,000 +33.6%
Value US$457,500
Malley Thomas Non-Executive Director
Transaction date
Purchase
Price
21.75
Quantity 8,068 +68.1%
Value US$175,479
Malley Thomas Non-Executive Director
Transaction date
Purchase
Price
21.75
Quantity 8,500 +253.7%
Value US$184,875
Malley Thomas Non-Executive Director
Transaction date
Purchase
Price
21.75
Quantity 3,350 +inf%
Value US$72,862
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
23.90
Quantity 3,700 +9.0%
Value US$88,430
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
21.10
Quantity 7,100 +21.0%
Value US$149,810
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
18.55
Quantity 1,000 +3.0%
Value US$18,550
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
18.85
Quantity 500 +1.5%
Value US$9,425
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
18.40
Quantity 5,500 +20.5%
Value US$101,200
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
18.30
Quantity 4,000 +17.5%
Value US$73,200
Belldegrun Arie Non-Executive Director
Transaction date
Purchase
Price
18.15
Quantity 4,000 +21.2%
Value US$72,600
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2009-06-10 2009-06-09 S Sale ROSENWALD LINDSAY A MD Large shareholder
80,524 -13.4%
46.14
US$3,895,705 		80,524 -13.4% 46.14 US$3,895,705
2008-03-03 2008-02-21 B Purchase Belldegrun Arie Non-Executive Director
83,646 -27.6%
477.19
US$947,290 		83,646 -27.6% 477.19 US$947,290
2008-03-03 2008-02-21 B Purchase Belldegrun Arie Non-Executive Director
439 -20.9%
416.82
US$4,226,600 		439 -20.9% 416.82 US$4,226,600
2007-12-20 2007-12-18 B Purchase Belldegrun Arie Non-Executive Director
15,000 +33.6%
30.50
US$457,500 		15,000 +33.6% 30.50 US$457,500
2007-07-20 2007-07-19 B Purchase Malley Thomas Non-Executive Director
8,068 +68.1%
21.75
US$175,479 		8,068 +68.1% 21.75 US$175,479
2007-07-20 2007-07-18 B Purchase Malley Thomas Non-Executive Director
8,500 +253.7%
21.75
US$184,875 		8,500 +253.7% 21.75 US$184,875
2007-07-20 2007-07-17 B Purchase Malley Thomas Non-Executive Director
3,350 +inf%
21.75
US$72,862 		3,350 +inf% 21.75 US$72,862
2007-06-19 2007-06-18 B Purchase Belldegrun Arie Non-Executive Director
3,700 +9.0%
23.90
US$88,430 		3,700 +9.0% 23.90 US$88,430
2007-05-10 2007-05-08 B Purchase Belldegrun Arie Non-Executive Director
7,100 +21.0%
21.10
US$149,810 		7,100 +21.0% 21.10 US$149,810
2007-03-09 2007-02-27 B Purchase Belldegrun Arie Non-Executive Director
1,000 +3.0%
18.55
US$18,550 		1,000 +3.0% 18.55 US$18,550
2007-03-09 2007-02-26 B Purchase Belldegrun Arie Non-Executive Director
500 +1.5%
18.85
US$9,425 		500 +1.5% 18.85 US$9,425
2007-03-09 2007-02-26 B Purchase Belldegrun Arie Non-Executive Director
5,500 +20.5%
18.40
US$101,200 		5,500 +20.5% 18.40 US$101,200
2007-03-09 2007-02-26 B Purchase Belldegrun Arie Non-Executive Director
4,000 +17.5%
18.30
US$73,200 		4,000 +17.5% 18.30 US$73,200
2007-03-09 2007-02-26 B Purchase Belldegrun Arie Non-Executive Director
4,000 +21.2%
18.15
US$72,600 		4,000 +21.2% 18.15 US$72,600
Explore more

More insider trading research around Janssen Oncology Inc

More insider trades in United States
Insider trading in North America